LUCY · Innovative Eyewear Inc · Metrics
Market Cap
$7.90M
Shares
8.61M
Volume · Oct 5
174.6K
Avg daily vol (3M)
7.73M
LUCY metrics
56 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$0.89
Market cap
$7.90M
Price action
20 metricsPrice change (1W)
-6.1%
Price change (30D)
+2.8%
Price change (3M)
+17.4%
Price change (6M)
-15.8%
Price change (YTD)
-10.5%
Price change (1Y)
-56.8%
Trailing year
Price change (5Y)
—
52-week high
$2.07
52-week low
$0.65
Change from 52-week high
-56.8%
Change from 52-week low
+37.0%
Annualized volatility
126.5%
Annualized volatility (3M)
199.3%
Beta
1.9
RSI (14D)
49.3
Price vs SMA 50
+6.6%
Price vs SMA 200
-12.7%
Avg volume (3M)
7.73M
Relative volume
0.0
Average dollar volume
$8.91M
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
8.61M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.3×
reciprocal yield 43.2%
P / book
1.1
reciprocal yield 87.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-97.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
22.8%
Operating margin
—
Trailing 12 months
Net margin
-225.3%
Gross profit (TTM)
$777,543
Operating profit (TTM)
—
Net income (TTM)
−$7.69M
Trailing 12 months
Diluted EPS (TTM)
$-1.15
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+74.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.41M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+99.2%
Year over year · more shares
Revenue CAGR (3Y)
+59.2%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-111.4%
Return on assets
-102.9%
Debt / equity
—
Current ratio
12.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
8.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$2.46M
Latest balance sheet
Cash & equivalents
$2.46M
Total assets
$7.47M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$7.20M
Capital expenditures (TTM)
$72,513
R&D (TTM)
$526,790
SG&A (TTM)
—
Stock compensation (TTM)
$795,197
R&D / revenue
15.4%
Stock compensation / revenue
23.3%
Ownership (13F)
3 metrics13F filers
15
13F filer change QoQ
+4
Institutional ownership
10.4%
Short interest
3 metricsShort interest
1.8%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
31 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—